Pharmaceuticals Market Research Reports

Global 3D Bioengineered Skin Grafts Market By Product Type (Bilayered, Biosynthetic/Hybrid, Dermal-only, Trilayered, Epidermal-only), By Application (Chronic Wounds, Acute Wounds (Burns, Trauma), Reconstructive & Plastic Surgery), By End-user (Hospitals, Specialized Wound Care Centers/Clinics, Ambulatory Surgical Centers, Research and Academic Institutes), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Report Overview Global 3D Bioengineered Skin Grafts Market size is expected to be worth around US$ 5.3 Billion by 2035 from US$ 2.3 Billion in 2025, growing at a CAGR of 8.6% during ...
- ★★★★★
  
  ★★★★★
  
  (142)
- July 2026
- Pages: 321
- US $3,999 Onwards
- Formats:
Global Central Nervous System Drugs Market By Disease (Mental Health/Psychiatric Disorders, Neurodegenerative Diseases, Pain Disorders, Epilepsy/Seizure Disorders, Neurovascular Diseases, Multiple Sclerosis, and Others), By Drug Class (Analgesics/Pain Relievers, Antidepressants, Antipsychotics, Anticonvulsants/Antiepileptics, Anti-Alzheimer's/Anti-Parkinson's Agents, CNS Stimulants, Anesthetics, Antiemetics, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), By Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026–2035.

Report Overview Global Central Nervous System Drugs Market size is expected to be worth around US$ 290.3 Billion by 2035 from US$ 128.7 Billion in 2025, growing at a CAGR of 8.5% dur...
- ★★★★★
  
  ★★★★★
  
  (142)
- June 2026
- Pages: 251
- US $3,999 Onwards
- Formats:
Global Antiviral Drugs Market By Drug Class (Nucleoside & Nucleotide Analogues, Protease Inhibitors, Integrase Inhibitors, Neuraminidase Inhibitors, Reverse Transcriptase Inhibitors, Fusion & Entry Inhibitors, Polymerase Inhibitors, and Others), By Indication (Human Immunodeficiency Virus (HIV), Hepatitis B, Hepatitis C, Influenza, Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Respiratory Syncytial Virus (RSV), COVID-19, and Others), By Route of Administration (Oral, Injectable, Topical, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Drug Type (Branded Drugs and Generic Drugs), By Age Group (Pediatric, Adult, and Geriatric), By Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026–2035

Report Overview Global Antiviral Drugs Market size is expected to be worth around US$ 98.0 Billion by 2035 from US$ 68.2 Billion in 2025, growing at a CAGR of 3.7% during the forecas...
- ★★★★★
  
  ★★★★★
  
  (70)
- June 2026
- Pages: 380
- US $3,999 Onwards
- Formats:
Global Test Strip Market By Product type (Blood glucose test strips, Urine test strips, Pregnancy & fertility test strips, Infectious‑disease & multi‑parameter test strips, Cholesterol & other specialized test strips), By Application (Diabetes management, Pregnancy & fertility testing, Kidney and urinary‑tract evaluation, Infectious‑disease diagnosis, Drug‑of‑abuse and general health screening, Cardiovascular & lipid monitoring), By Technology (Electrochemical test strips, Lateral‑flow assay (LFA) test strips, Optical / colorimetric test strips ,Biosensor‑enhanced, Others), By Distribution channel (Retail pharmacies, Hospital pharmacies, Online pharmacies, Direct institutional / tenders), By End Use (Hospitals & clinics, Home‑care/self‑testing users, Diagnostic laboratories, Pharmacies & retail clinics, Research institutes & others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Report Overview Global Test Strip Market size is expected to be worth around US$ 15.1 Billion by 2035 from US$ 10.8 Billion in 2025, growing at a CAGR of 3.4% during the forecast ...
- ★★★★★
  
  ★★★★★
  
  (142)
- June 2026
- Pages: 228
- US $3,999 Onwards
- Formats:
Global Chronic Disorder Drugs Market By Therapy (Small-Molecule Drugs, Biologics & Targeted Therapies, Supportive/Adjunctive Therapies), By Disease (Cardiovascular, Diabetes, Respiratory, Cancer & Other Chronic Conditions), By Route of Administration (Oral, Parenteral, Inhaled & Other), By Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025–2035

Report Overview In 2025, the Global Chronic Disorder Drugs Market was valued at US$ 7.1 Billion, and between 2026 and 2035, this market is estimated to register a CAGR of 14.1%, reac...
- ★★★★★
  
  ★★★★★
  
  (142)
- June 2026
- Pages: 312
- US $3,999 Onwards
- Formats:
Global Vutrisiran Market By Product Type (Antisense Oligonucleotide, Nucleotide, Nucleic Acids, Nucleoside and Others), By Route of Administration (Oral, Subcutaneous and Injectable), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Report Overview Global Vutrisiran Market size is expected to be worth around US$ 3.2 Billion by 2035 from US$ 0.9 billion in 2025, growing at a CAGR of 13.4% during the forecast peri...
- ★★★★★
  
  ★★★★★
  
  (142)
- Feb 2026
- Pages: 322
- US $3,999 Onwards
- Formats:

« Previous 1 2 3 4 5 … 71 Next »